Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

FDA Approves Insmed's Drug

Reuters on MSN · 1d
US FDA approves Insmed's drug as first treatment for a chronic lung disease
The U.S. Food and Drug Administration has approved Insmed's oral drug for a type of lung disease, the company said on Tuesday, making it the first treatment for the chronic condition.
pharmaphorum · 16h
Insmed gets first FDA approval for bronchiectasis
Insmed has claimed the distinction of becoming the first company to get FDA approval for a treatment for chronic lung disease non-cystic fibrosis bronchiectasis (NFCB).
PharmExec · 1d
FDA Approves Insmed’s Brinsupri as First Treatment for Non-Cystic Fibrosis Bronchiectasis
Brinsupri is a first-in-class DPP1 inhibitor that has been found to inhibit activation of neutrophil enzymes that drive chronic airway inflammation in non-cystic fibrosis bronchiectasis.
2don MSN

GSK's antibiotic gets FDA priority review for oral treatment of gonorrhoea

British drugmaker GSK said on Monday that the U.S. Food and Drug Administration has accepted its application for priority ...
Hosted on MSN20d

New medications coming soon: Here’s what’s been FDA approved ... - MSN

Every year, the FDA approves novel drugs, biosimilars, and first generics. Compared to 2024, novel drug and biosimilar approval numbers are slightly behind in the first half of 2025.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Unveils award nominees
Receives $300 million gift
To suspend flights
Says he has ‘no tumors’
US woman found guilty
Pioneering jazz singer dies
'Drag Me to Hell' star dies
NY AG sues Zelle
Broadens 10% staff discount
Says ‘Putin is bluffing’
Ordered to improve facility
Trump warns Russia
Announces $3B+ investment
Foreign aid freeze upheld
New human species found?
Musk loses court bid
Ordered to restore funding
Cheese products recalled
To buy HanesBrands
Coffee recalled
To extend DC police takeover
Expands same-day delivery
Launches Smithsonian review
To recall 121K+ vehicles
Alaska’s glacier flood threat
Provisionally suspended
Sanctions MX drug cartel
Tennessee flash flooding
Man charged w/ cyberstalking
Southern Europe wildfires
May go out of business
Could be sentenced soon
Migrant boat capsizes
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy